BioCentury
ARTICLE | Company News

Celera Genomics Group, Bayer deal

October 14, 2002 7:00 AM UTC

CRA purchased all rights and compounds under a 1994 asthma deal between BAY and Axys, which CRA acquired last year. CRA also will receive study data and relevant IP relating to oral treatments for ast...